Fingerprint
Dive into the research topics of 'Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically